These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 19952150

  • 21. [Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting].
    Sicras-Mainar A, Blanca-Tamayo M, Gutiérrez-Nicuesa L, Salvatella-Pasant J, Navarro-Artieda R.
    Gac Sanit; 2010; 24(1):13-9. PubMed ID: 19646795
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians.
    Simon GE, Von Korff M, Rutter CM, Peterson DA.
    Arch Gen Psychiatry; 2001 Apr; 58(4):395-401. PubMed ID: 11296101
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M, Beneitez I, Peñarrubia-María MT, Luciano JV, Mendive JM, McCrone P, Knapp M, Sabés-Figuera R, Kocyan K, García-Campayo J, Serrano-Blanco A.
    BMC Psychiatry; 2015 Mar 31; 15():63. PubMed ID: 25885818
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW, Neslusan C, Ricci JF, Wang S, Khan ZM, Kwong JW.
    Value Health; 2001 Mar 31; 4(5):362-9. PubMed ID: 11705126
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.
    Ann Pharmacother; 2012 May 31; 46(5):642-9. PubMed ID: 22550279
    [Abstract] [Full Text] [Related]

  • 34. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M, Moride Y, Crott R, du Fort GG, Ducruet T.
    J Affect Disord; 2009 May 31; 115(1-2):160-6. PubMed ID: 18694602
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.
    Cui Z, Faries DE, Zhao Y, Novick D, Liu X.
    J Med Econ; 2011 May 31; 14(5):662-72. PubMed ID: 21892857
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL, Candrilli SD, Edin HM.
    Epilepsia; 2008 Mar 31; 49(3):446-54. PubMed ID: 18031549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.